Why Are ResMed (ASX:RMD) and TechnologyOne (ASX:TNE) Long-Term ASX Shares to Watch?

3 min read | July 10, 2026 09:58 AM AEST | By Sam

Highlights

  • ResMed continues expanding its connected healthcare and sleep therapy business across global markets.
  • TechnologyOne is strengthening its cloud software platform through long-term customer relationships and recurring revenue.
  • Healthcare innovation and enterprise software remain important structural growth themes across the Australian market.

ResMed Inc (ASX:RMD) and TechnologyOne Ltd (ASX:TNE) continue attracting attention as two established Australian companies operating in industries supported by long-term structural demand. While they serve very different markets, both businesses have built strong positions through innovation, recurring customer relationships and ongoing investment in technology. As prominent constituents of the ASX 100, both companies remain closely followed within ASX Growth Stocks.

Why is ResMed attracting attention?

ResMed continues focusing on sleep health, respiratory care and connected healthcare technologies.

Its product portfolio supports patients through integrated medical devices, digital monitoring and healthcare software designed to improve long-term patient management.

The company's business continues benefiting from growing awareness of sleep-related health conditions and broader adoption of connected healthcare solutions.

Connected healthcare continues evolving

Healthcare providers are increasingly adopting digital technologies that improve patient care and monitoring.

Several trends continue supporting this transition.

Sleep health

Growing awareness continues supporting diagnosis and treatment.

Connected devices

Digital monitoring enables ongoing patient management.

Home healthcare

More care continues moving beyond traditional hospital settings.

Healthcare technology

Innovation remains central to improving patient outcomes.

These long-term trends continue supporting the healthcare technology sector.

Why is TechnologyOne attracting attention?

TechnologyOne develops enterprise software used by government agencies, educational institutions and large organisations.

Its cloud-based platform supports essential business functions including:

  • Financial management
  • Human resources
  • Property management
  • Student administration
  • Enterprise reporting

The company continues expanding its software ecosystem while strengthening long-term customer relationships.

Cloud software remains a long-term growth theme

Enterprise software continues evolving as organisations modernise digital infrastructure.

Cloud-based platforms provide businesses with:

Operational efficiency

Streamlining business processes.

Digital transformation

Replacing traditional enterprise systems.

Ongoing software updates

Supporting continuous platform improvements.

Long-term customer relationships

Subscription models encourage ongoing engagement.

These characteristics continue supporting demand for enterprise software.

Artificial intelligence supports software development

TechnologyOne has continued investing in artificial intelligence to enhance its software platform.

AI technologies increasingly assist organisations by improving:

  • Workflow automation
  • Operational efficiency
  • Data analysis
  • Decision support
  • Customer experience

Artificial intelligence continues becoming an important component of enterprise software development.

Different industries, similar long-term themes

Although ResMed and TechnologyOne operate in different sectors, both businesses benefit from long-term structural trends.

ResMed focuses on healthcare technology, while TechnologyOne supports digital transformation through enterprise software.

Both companies emphasise:

  • Innovation
  • Technology investment
  • Customer retention
  • Global or diversified customer bases
  • Long-term business development

These characteristics continue attracting attention across Australia's technology and healthcare sectors.

Australia's healthcare and technology sectors continue evolving

Healthcare and enterprise software remain two areas experiencing ongoing digital transformation.

Companies operating in these industries continue responding to:

Healthcare innovation

Expanding digital patient care.

Cloud computing

Increasing software adoption across organisations.

Artificial intelligence

Supporting smarter digital solutions.

Digital services

Improving operational efficiency across industries.

These trends continue shaping future commercial opportunities.

What could remain in focus?

Several developments remain important.

ResMed

Continued healthcare innovation and connected device adoption.

TechnologyOne

Cloud software expansion and enterprise platform development.

Artificial intelligence

Ongoing integration across healthcare and software solutions.

Customer growth

Long-term relationships remain central to both businesses.

These themes continue supporting market attention.

ResMed and TechnologyOne continue demonstrating how Australian companies can build strong market positions through innovation, technology and long-term customer relationships. While operating in different industries, both businesses remain aligned with structural trends supporting healthcare technology and enterprise software. As these industries continue evolving, both companies remain important names to watch across Australia's listed market.

Frequently Asked Questions

  • What does ResMed specialise in?
    ResMed develops sleep health, respiratory care and connected healthcare technologies.
  • What products does TechnologyOne provide?
    TechnologyOne develops cloud-based enterprise software for government, education and commercial organisations.
  • Which ASX index includes these companies?
    ResMed and TechnologyOne are constituents of the ASX 100.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.